Similarly, combining 1MT with the nicotinamide phosphoribosyl transferase (NAMPT) inhibitor, APO866, resulted in a greater effect on both murine gastric and bladder tumor models than either treatment alone [169]. Here, NAMPT is linked to urinary bladder neoplasm.